This makes Miro1 not only a mechanistic bridge between organelle motility and intercellular communication, but also a promising therapeutic target: one that can be upregulated to enhance tissue repair or potentially inhibited to block pathological mitochondrial exchange, such as in tumor–stromal interactions. This evidence concerns the gene RHOT1 and neoplasm.